Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -116,168 | -79,678 | -40,977 | -102,678 | -95,223 |
| Depreciation Amortization | 21,736 | 14,095 | 32,517 | 22,448 | 15,518 |
| Accounts receivable | -3,989 | -2,396 | 40 | 152 | 1,346 |
| Accounts payable and accrued liabilities | 4,962 | 6,305 | -3,103 | -2,708 | 6,991 |
| Other Working Capital | -2,549 | 1,921 | -2,668 | 10,613 | 7,820 |
| Other Operating Activity | 42,286 | 20,152 | -6,301 | 47,215 | 42,155 |
| Operating Cash Flow | $-53,722 | $-39,601 | $-20,492 | $-24,958 | $-21,393 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,868 | 21,186 | -7,432 | -168,590 | -123,654 |
| PPE Investments | -286 | -21 | -19 | -727 | -727 |
| Purchase Of Investment | N/A | N/A | N/A | -15,000 | -15,000 |
| Purchase Sale Intangibles | -11,299 | -7,347 | -3,961 | -18,974 | -15,108 |
| Other Investing Activity | -11,299 | -7,347 | -3,961 | -18,974 | -15,108 |
| Investing Cash Flow | $18,283 | $13,818 | $-11,412 | $-203,291 | $-154,489 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 235,797 | 235,797 |
| Common Stock Issued | 944 | 317 | 304 | 15,893 | 14,653 |
| Other Financing Activity | -3,116 | -1,751 | -1,414 | -19,827 | -19,112 |
| Financing Cash Flow | $-2,172 | $-1,434 | $-1,110 | $231,863 | $231,338 |
| Exchange Rate Effect | -74 | 1 | -21 | -135 | -30 |
| Beginning Cash Position | 102,873 | 102,873 | 102,873 | 99,394 | 99,394 |
| End Cash Position | 65,188 | 75,657 | 69,838 | 102,873 | 154,820 |
| Net Cash Flow | $-37,685 | $-27,216 | $-33,035 | $3,479 | $55,426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,722 | -39,601 | -20,492 | -24,958 | -21,393 |
| Capital Expenditure | -286 | -21 | -19 | -727 | -727 |
| Free Cash Flow | -54,008 | -39,622 | -20,511 | -25,685 | -22,120 |